250 related articles for article (PubMed ID: 8571707)
1. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
4. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G
Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862
[TBL] [Abstract][Full Text] [Related]
7. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides.
Jachimczak P; Fabel-Schulte K; Hessdörfer B; Brysch W; Schlingensiepen KH; Blesch A; Bogdahn U
Cell Immunol; 1995 Oct; 165(1):125-33. PubMed ID: 7671316
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells.
Wiechen K; Dietel M
Int J Cancer; 1995 Nov; 63(4):604-8. PubMed ID: 7591273
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P
Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
Gong ZB; Liu JM; Li YM
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
[TBL] [Abstract][Full Text] [Related]
12. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
Yang DC; Jiang X; Elliott RL; Head JF
Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
[TBL] [Abstract][Full Text] [Related]
13. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth.
Wang X; Zhang R; Xie H
Chin Med J (Engl); 1999 Aug; 112(8):743-6. PubMed ID: 11601286
[TBL] [Abstract][Full Text] [Related]
16. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effects of antisense focal adhesion kinase oligodeoxynucleotides on the invasion of Bel 7402 hepatocellular carcinoma cells].
Gu Y; Chen JS; Zhou XD
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):612-5. PubMed ID: 14572340
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
